The earnings call presented a mixed outlook with strong brand performance and strategic expansions offset by flat revenue growth, increased net loss, and retail revenue decline. The company's focus on wholesale growth and new product launches shows promise, but operational challenges remain.

Company Guidance -

Q3 2025

During MariMed Incorporated's First Quarter 2025 Financial Results Conference Call, the company provided several key metrics and strategic insights. Revenue for Q1 2025 was reported as flat year-over-year at $38 million, with a slight sequential decline of 2.7% due to seasonal impacts. The company's wholesale revenue grew by 16% year-over-year, now accounting for 44% of total revenue, up from 42% sequentially. Non-GAAP adjusted gross margin decreased to 41.3%, down from 43.8% the previous year, primarily due to price compression and increased costs from new facilities. MariMed reported a net loss of $5.4 million, compared to $1.3 million in the same period last year. Operating expenses rose to $16 million, partly due to a one-time receivable write-off. The company anticipates high single-digit revenue growth in Q2 2025 driven by wholesale expansion and promotional activities. They are also exploring new revenue sources, including a potential entry into the hemp market and the launch of new products like Microdose by Nature's Heritage, which leverages the growing trend of functional mushrooms.

Expansion in Storefronts

MariMed's brands were sold into 70 new storefronts during the quarter, contributing to an increase in wholesale revenue, which now accounts for 44% of the company's revenue mix, up from 42% sequentially.

Wholesale Growth

Wholesale gross revenue increased 16% compared to the prior year quarter and 4% sequentially, driven by increased market penetration.

Strong Brand Performance

In Illinois, the company's products were sold into more than 180 stores, representing a 5% increase sequentially and 46% year-on-year. Betty's, Vibations, and Bubby's brands performed well in multiple states, with Betty's climbing to number 5 in Illinois and maintaining the number 1 position in Massachusetts.

Community Support Initiatives

MariMed's Help on the Homefront program raised funds to assist veterans with housing costs, highlighting the company's commitment to community support.

New Product Launch

The introduction of Microdose by Nature's Heritage, a new product format focusing on functional mushrooms, was launched in Massachusetts and is expected to gain traction.

Strategic M&A and Licensing Opportunities

The acquisition of First State Compassion was completed, and MariMed is in discussions for licensing opportunities in new markets, which could expand brand distribution and market share.

MariMed (MRMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MRMD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.01 / -	0.004	―	―	―
Aug 06, 2025	2025 (Q2)	-0.01 / 0.00	-0.001	―	―
May 07, 2025	2025 (Q1)	-0.01 / -0.01	0	―	―
Mar 05, 2025	2024 (Q4)	-0.01 / -0.02	0.001	-2100.00% (-0.02)	―
Nov 06, 2024	2024 (Q3)	-0.01 / <0.01	-0.01	140.00% (+0.01)	―
Aug 07, 2024	2024 (Q2)	-0.01 / >-0.01	0.002	-150.00% (>-0.01)	―
May 08, 2024	2024 (Q1)	-0.01 / 0.00	0.001	―	―
Mar 06, 2024	2023 (Q4)	0.00 / <0.01	0.01	-90.00% (>-0.01)	―
Nov 08, 2023	2023 (Q3)	>-0.01 / -0.01	0.01	-200.00% (-0.02)	―
Aug 02, 2023	2023 (Q2)	0.00 / <0.01	0	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MRMD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$0.11	$0.10	-9.09%
May 07, 2025	$0.10	$0.10	0.00%
Mar 05, 2025	$0.12	$0.11	-8.33%
Nov 06, 2024	$0.15	$0.15	0.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does MariMed Inc (MRMD) report earnings?

MariMed Inc (MRMD) is schdueled to report earning on Nov 05, 2025, TBA (Confirmed).

What is MariMed Inc (MRMD) earnings time?

MariMed Inc (MRMD) earnings time is at Nov 05, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MRMD EPS forecast?

MRMD EPS forecast for the fiscal quarter 2025 (Q3) is -0.01.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing